Можливості впровадження біоекономіки у фармацевтичні підприємства
This study examines the bioeconomy’s role in the pharmaceutical sector, emphasizing biotechnology’s impact and forecasts for biological products up to 2028. It highlights growth trends and significance, alongside employment and productivity metrics in 2015 and 2020. A case study on Gilead Sciences i...
Збережено в:
| Дата: | 2024 |
|---|---|
| Автори: | , |
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Odesa National University of Technology
2024
|
| Онлайн доступ: | //journals.ontu.edu.ua/index.php/fie/article/view/2941 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Food Industry Economics |
Репозитарії
Food Industry Economics| Резюме: | This study examines the bioeconomy’s role in the pharmaceutical sector, emphasizing biotechnology’s impact and forecasts for biological products up to 2028. It highlights growth trends and significance, alongside employment and productivity metrics in 2015 and 2020. A case study on Gilead Sciences illustrates how biotechnology influences its growth, and a flowchart outlines future bioeconomy development. The bioeconomy utilizes biological resources to create products that enhance environmental sustainability and human health. The dynamic pharmaceutical industry, focused on medication research and production, requires effective entrepreneurial coordination. Entrepreneurship is characterized by competitiveness, risk-taking, and market opportunities and intersects with bioeconomy and pharmaceuticals. It empowers pharmaceutical firms to develop eco-friendly, effective drugs and fosters collaboration essential for advancing biological innovations. By adopting bioeconomic principles, pharmaceutical companies can enhance public health and promote sustainable resource use. |
|---|